NEW YORK, NY / ACCESSWIRE / January 26, 2020 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
FSCT Shareholders Click Here: https://www.zlk.com/pslra-1/forescout-technologies-inc-loss-form?prid=5355&wire=1
PRU Shareholders Click Here: https://www.zlk.com/pslra-1/prudential-financial-inc-loss-form?prid=5355&wire=1
GERN Shareholders Click Here: https://www.zlk.com/pslra-1/geron-corporation-et-al-loss-form?prid=5355&wire=1
* ADDITIONAL INFORMATION BELOW *
Forescout Technologies, Inc. (FSCT)
FSCT Lawsuit on behalf of: investors who purchased February 7, 2019 - October 9, 2019
Lead Plaintiff Deadline : March 2, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/forescout-technologies-inc-loss-form?prid=5355&wire=1
According to the filed complaint, during the class period, Forescout Technologies, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Forescout was experiencing significant volatility with respect to large deals and issues related to the timing and execution of deals in the Company's pipeline, especially in Europe, the Middle East, and Africa; (ii) the foregoing was reasonably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Prudential Financial, Inc. (PRU)
PRU Lawsuit on behalf of: investors who purchased February 15, 2019 - August 2, 2019
Lead Plaintiff Deadline : January 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/prudential-financial-inc-loss-form?prid=5355&wire=1
According to the filed complaint, during the class period, Prudential Financial, Inc. made materially false and/or misleading statements and/or failed to disclose that: (a) the Company's reserve assumptions failed to account for adversely developing mortality experience in the Individual Life business segment; (b) the Company was not over-reserved, but instead, its reported reserves, particularly for the Individual Life business segment, were insufficient to satisfy its future policy benefits liabilities; and (c) the Company had materially understated its liabilities and overstated net income as a result of flawed assumptions in calculating mortality experience.
Geron Corporation (GERN)
GERN Lawsuit on behalf of: investors who purchased March 19, 2018 - September 26, 2018
Lead Plaintiff Deadline : March 23, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/geron-corporation-et-al-loss-form?prid=5355&wire=1
The filed complaint alleges that defendants misled investors regarding a drug called imetelstat, which was intended to treat certain cancers that occur in bone marrow. Specifically, defendants misled investors about the results of a clinical drug study of imetelstat called IMbark. That study was designed to ascertain whether imetelstat helped patients with a cancer called myelofibrosis.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com: